For the fourth quarter of 2016 (ending Dec. 31, 2016), Madison-based Exact Sciences Corp. generated $35.2 million in revenue and completed about 82,000 Cologuard tests for colon cancer.
That compares to revenues of $14.4 million for the same quarter in 2015.
The company also narrowed its net loss year over year from $40.0 million (41 cents/share) in the fourth quarter of 2015 to $37.2 million (34 cents/share) a year later.
For all of 2016, Exact Sciences generated $99.4 million in revenues (+152%) and completed about 244,000 tests (+135%) compared to 2015.
Advertisement
